FR2381525A1 - Compositions pharmaceutiques antioestrogenes - Google Patents

Compositions pharmaceutiques antioestrogenes

Info

Publication number
FR2381525A1
FR2381525A1 FR7805566A FR7805566A FR2381525A1 FR 2381525 A1 FR2381525 A1 FR 2381525A1 FR 7805566 A FR7805566 A FR 7805566A FR 7805566 A FR7805566 A FR 7805566A FR 2381525 A1 FR2381525 A1 FR 2381525A1
Authority
FR
France
Prior art keywords
compound
tamoxifen
estrogen
exhibits
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7805566A
Other languages
English (en)
French (fr)
Other versions
FR2381525B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of FR2381525A1 publication Critical patent/FR2381525A1/fr
Application granted granted Critical
Publication of FR2381525B1 publication Critical patent/FR2381525B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7805566A 1977-02-28 1978-02-27 Compositions pharmaceutiques antioestrogenes Granted FR2381525A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8273/77A GB1560274A (en) 1977-02-28 1977-02-28 Phenylbut 1-ene derivatives having antiostrogenicactivity

Publications (2)

Publication Number Publication Date
FR2381525A1 true FR2381525A1 (fr) 1978-09-22
FR2381525B1 FR2381525B1 (enExample) 1980-08-29

Family

ID=9849341

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7805566A Granted FR2381525A1 (fr) 1977-02-28 1978-02-27 Compositions pharmaceutiques antioestrogenes

Country Status (9)

Country Link
US (1) US4198435A (enExample)
JP (1) JPS53107425A (enExample)
AU (1) AU515458B2 (enExample)
BE (1) BE864359A (enExample)
DE (1) DE2807599C2 (enExample)
FR (1) FR2381525A1 (enExample)
GB (1) GB1560274A (enExample)
NL (1) NL7801739A (enExample)
NZ (1) NZ186403A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2401132A1 (fr) * 1977-08-22 1979-03-23 Ici Ltd Nouveaux derives de triphenylbutene-1, leur procede de production et composition pharmaceutique les contenant

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE637389A (enExample) * 1962-09-13
ATE2423T1 (de) * 1978-11-07 1983-03-15 Imperial Chemical Industries Plc 1-acyloxyphenyl-1,2-diphenylalken-derivate, verfahren zu deren herstellung und eine diese derivate enthaltende pharmazeutische zusammensetzung.
DE3046719C2 (de) * 1980-12-11 1983-02-17 Klinge Pharma GmbH, 8000 München 1,1,2-Triphenyl-but-1-en-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel
CA1289570C (en) * 1986-06-16 1991-09-24 Tetsuji Asao 1,1,2-triaryl-1-alkene derivatives
EP0287690B1 (de) * 1987-04-21 1992-09-02 HEUMANN PHARMA GMBH & CO Stabile Lösungsmitteladdukte von Z-1-(p-beta-Dimethylamino-ethoxyphenyl)-1-(p-hydroxyphenyl)-2-phenylbut-1-en
US5204337A (en) * 1988-10-31 1993-04-20 Endorecherche Inc. Estrogen nucleus derivatives for use in inhibition of sex steroid activity
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
DE4320896A1 (de) * 1993-06-24 1995-01-05 Denecke Rainer Dr Med Vet Präparat zur Therapie und Prophylaxe von Demenz-Erkrankungen
DE4407742C1 (de) * 1994-03-08 1995-06-22 Hexal Pharma Gmbh Transdermales System in Form eines Pflasters mit einem Tamoxifen-Derivat
US5681835A (en) * 1994-04-25 1997-10-28 Glaxo Wellcome Inc. Non-steroidal ligands for the estrogen receptor
ATE232743T1 (de) * 1994-06-27 2003-03-15 Neutron Therapies Inc Bor enthaltende hormonanaloga und verfahren fuer ihre verwendung zur bildlichen darstellung oder zum abtoeten von zellen, die hormonrezeptoren besitzen
ATE411016T1 (de) 1997-08-15 2008-10-15 Univ Duke Verfahren zur prophylaxis oder behandlung von östrogen-abhängigen krankheiten
US6245352B1 (en) * 1999-04-27 2001-06-12 Eli Lilly And Company Pharmaceutical formulation
ATE301129T1 (de) 1999-05-04 2005-08-15 Strakan Int Ltd Androgen glykoside und die androgenische aktivität davon
US20030032676A1 (en) * 2001-08-09 2003-02-13 Kimelberg Harold K. Drugs for treatment of cerebral injury and methods of use thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1568834A1 (de) * 1962-09-13 1970-11-26 Ici Ltd Verfahren zur Herstellung von cis- und trans-Isomeren von Alkenderivaten

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1568834A1 (de) * 1962-09-13 1970-11-26 Ici Ltd Verfahren zur Herstellung von cis- und trans-Isomeren von Alkenderivaten

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2401132A1 (fr) * 1977-08-22 1979-03-23 Ici Ltd Nouveaux derives de triphenylbutene-1, leur procede de production et composition pharmaceutique les contenant

Also Published As

Publication number Publication date
AU515458B2 (en) 1981-04-02
AU3319078A (en) 1979-08-16
NZ186403A (en) 1984-08-24
JPS53107425A (en) 1978-09-19
BE864359A (fr) 1978-08-28
NL7801739A (nl) 1978-08-30
FR2381525B1 (enExample) 1980-08-29
DE2807599A1 (de) 1978-08-31
DE2807599C2 (de) 1987-04-09
US4198435A (en) 1980-04-15
GB1560274A (en) 1980-02-06
JPS6339567B2 (enExample) 1988-08-05

Similar Documents

Publication Publication Date Title
FR2381525A1 (fr) Compositions pharmaceutiques antioestrogenes
Thompson et al. Sulfone metabolite of sulindac inhibits mammary carcinogenesis
TNSN94035A1 (fr) Composition veterinaire
FR2448348A1 (fr) Composition pharmaceutique comprenant une acyl-carnitine pour le traitement du metabolisme cerebral perturbe
FR2404625A1 (fr) Nouveaux 4-aminocyclohexanols et composition pharmaceutique les contenant
FR2451913A1 (fr) Derives de la glycinamide, leur preparation et leur utilisation dans le traitement de diverses formes d'epilepsie, des dyskinesies et des troubles de la memoire
TNSN96104A1 (fr) Trihydrate de metahensulfonate de (1s,2s)-1-(4-hydroxyphenyl) -2-(4-hydroxy-4-phenylpiperidine-1-yl)-1-propanol et composition pharmaceutique le contenant
ATE221776T1 (de) Zusammensetzungen, die einen die mastzellendgranulation blockierenden h-1 rezeptorantagonisten als wirkstoff enthalten, für die behandlung von endogenen, schmerzhaften gastrointestinalen beschwerden nichtentzündlichen,nichtulzerativen ursprungs
FR2445146A1 (fr) Medicament a prise orale contenant une substance inhibitrice de l'inflammation et un ou plusieurs phospholipides
TNSN97087A1 (fr) 4(3h)-quinazolinones 2,3-disubstituees nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99203A1 (fr) Compositions pharmaceutiques pour le traitement de la migraine, et procede pour leur preparation
BE904921A (fr) Procedes et compositions pour le traitement de troubles gastro-intestinaux.
CA2330500A1 (fr) Compositions pharmaceutiques gelifiables
TNSN98150A1 (fr) Derives d'acides aryloxyarylsulfonylaminohydroxamiques ; procede pour leur preparation et compositions pharmaceutiques les contenant
FR2364030A1 (fr) Compositions pharmaceutiques a base d'anthocyanidines et procede pour leur preparation
TNSN99132A1 (fr) Une composition pour la prevention et/ou le traitement de l'osteoporose ou des alterations dues au syndrome de menopause
NO962841D0 (no) Anvendelse av 2-hydroksy-5-fenylazobenzosyrederivater som colon cancer kjemopreventativer og kjemoterapeutiske midler
CA2231342A1 (fr) Composition pharmaceutique pour administration par voie orale
KR840007714A (ko) 카르복실산 아마이드류의 제조방법
EP0065513A1 (en) SYNERGISTIC ANTIMYCOTIC PHARMACEUTICAL COMPOSITIONS AND THEIR PREPARATION METHOD.
KR950031060A (ko) 골다공증 치료용 약제학적 조성물
MA53010B1 (fr) Formulations d'un inhibiteur de axl/mer
DK160129C (da) Farmaceutisk praeparat indeholdende en gangliosidforbindelse, et indre ester-gangliosidderivat eller blandinger deraf
FR2387033A1 (fr) Composition therapeutique contenant une ou plusieurs substances actives chimiquement modifiees
Chatterjee et al. Reversible alteration of hepatic messenger RNA species for peroxisomal and non-peroxisomal proteins induced by the hypolipidaemic drug Wy-14,643